<DOC>
	<DOCNO>NCT00318773</DOCNO>
	<brief_summary>Serotonergic antidepressant clearly effective premenstrual syndrome ( PMS ) . This study compare short-term treatment ( 4 month ) long-term treatment ( 12 month ) sertraline determine long medication continue achieve good response , soon symptom return stop medication , whether symptom improve long-term treatment . Multiple hypothesis include follow : The percent relapse subject great short-term treatment ; relapse swifter short-term treatment ; relapse subject improve swiftly return medication ; patient satisfaction quality life improve long-term treatment .</brief_summary>
	<brief_title>Short-Term Versus Long-Term Treatment Severe Premenstrual Syndrome ( PMS )</brief_title>
	<detailed_description>Severe PMS chronic complex mood disorder involve mood , behavioral physical symptom link menstrual cycle severity disrupt function much several week menstrual cycle . Estimates indicate 20-25 % menstruate woman experience severe PMS . The efficacy serotonergic antidepressant clearly demonstrate severe form PMS short-term treatment trial . This study compare short-term treatment ( 4 month ) long-term treatment ( 12 month ) sertraline randomize , placebo-controlled design . The purpose determine long medication continue follow symptom relief , extent rapidly symptoms return stop medication , whether additional improvement long-term treatment . Following screen period 2-3 menstrual cycle include placebo-treated cycle , eligible woman randomize double-blind short-term long-term treatment arm . Subjects switch ( double-blind ) placebo 4 month 12 month sertraline treatment . All subject continue study total 21 month receive either sertraline match placebo interval . Subjects whose symptom return give open-label sertraline without break study blind . Subjects rate symptom daily throughout study use Penn Daily Symptom Report . Other assessment conduct monthly interval include Clinical Global Impressions Rating Scale , Sheehan Disability Scale , Hamilton Depression Rating Scale , Endicott Quality Life Questionnaire Cohen Perceived Stress Scale . The overall duration study expect 5-6 year .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Women PMS least 1 year . Ages 1845 year Regular menstrual cycle normal range ( 2236 day ) least 6 month In general good health determine physical examination blood test . Evidence ovulation use urine test . Meeting state criterion PMS . Signed informed consent . Any prescription , overthecounter , herbal nonmedical therapy PMS . Use psychotropic medication stop duration study . Other current psychiatric diagnosis determine SCID interview . Alcohol substance abuse/dependence suicide attempt within past 12 month ; lifetime history psychosis , bipolar disorder clearly identifiable severe personality disorder . Hysterectomy , symptomatic endometriosis , irregular menstrual cycle , severe unstable medical illness . Lack medicallyapproved contraception , currently pregnant , intention become pregnant breast feeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>PMS</keyword>
	<keyword>PMDD</keyword>
	<keyword>sertraline</keyword>
	<keyword>antidepressant</keyword>
	<keyword>extend treatment</keyword>
	<keyword>relapse</keyword>
</DOC>